An editorial notes that although the “headline news” of a global decline in the prevalence of rheumatic heart disease described in this study may give cause for optimism, the burden remains great for those parts of the world least able to afford it. It warns that “without sustained reengagement of clinicians, researchers, funders, and public health bodies, the menace of rheumatic heart disease is unlikely to be eliminated in the near future.”